Form 497K Global X Funds
April 1, 2024 Global X Clean Water ETF NASDAQ: AQWA 2024 Summary ProspectusBefore you invest, you may want to review the Fund's prospectus, which contains more information about the Fund and its risks. You can find the Fund's prospectus and other information about the Fund (including the Fund’s statement of additional information and annual report) online at http://www.globalxetfs.com/funds/aqwa. You can also get this information at no cost by calling... (continue reading...)
Form 10-D Morgan Stanley Capital For: Mar 15
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549
FORM 10-D
ASSET BACKED ISSUER DISTRIBUTION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the monthly distribution period from: February 17, 2024 to March 15, 2024
Commission File Number of issuing entity: 333-227446-05
Central Index Key Number of issuing entity: 0001778749
Morgan Stanley Capital I Trust 2019-H7(Exact name of issuing entity as... (continue reading...)
More SEC Filings
View Older Stories-
Form 497K Global X Funds
-
Form SC 13G SPRUCE BIOSCIENCES, INC. Filed by: Radoff Bradley Louis
-
Form 497K Global X Funds
-
Form 4 ESSA Pharma Inc. For: Mar 25 Filed by: ZWEIFACH SANFORD S
-
Form 497K Global X Funds
-
Form 10-D Morgan Stanley Capital For: Mar 15
-
Form 497K Global X Funds
-
Form 497K TRANSAMERICA SERIES TRUS
-
Form NPORT-P EATON VANCE MUTUAL FUNDS For: Jan 31
-
Form 497K Global X Funds
-
Form ABS-EE Morgan Stanley Capital For: Mar 15
-
Form 4 ESSA Pharma Inc. For: Mar 25 Filed by: Thorell Marella
-
Form 24F-2NT TIAA-CREF LIFE FUNDS For: Dec 31
-
Form 24F-2NT SEPARATE ACCOUNT VA-8 For: Dec 31
-
Form 497K Global X Funds
-
Form 24F-2NT SEPARATE ACCOUNT FUND C For: Dec 31
-
Form 10-D BANK 2020-BNK26 For: Mar 15
-
Form 497K Global X Funds
-
Form 497 PINNACLE SERIES ACCOUNT
-
Form 4 ESSA Pharma Inc. For: Mar 25 Filed by: Sollis Gary
-
Form ABS-EE Morgan Stanley Capital For: Mar 15
-
Form 424B2 UBS AG
-
Form S-3/A TREASURE GLOBAL INC
-
Form 497K Global X Funds
-
Form 497 TRANSAMERICA SERIES TRUS
-
Form 4 ESSA Pharma Inc. For: Mar 25 Filed by: Requadt Scott
-
Form 497 MAXIM SERIES ACCOUNT OF
-
Form DEF 14A ASSET MANAGEMENT FUND For: May 21
-
Form ABS-EE BANK 2020-BNK26 For: Mar 15
-
Form FWP UBS AG Filed by: UBS AG
-
Form 24F-2NT SEPARATE ACCOUNT FUND B For: Dec 31
-
Form 4 ESSA Pharma Inc. For: Mar 25 Filed by: Merendino Lauren
-
Form 24F-2NT ICMG REGISTERED VARIABLE For: Dec 31
-
Form 24F-2NT Voya VARIABLE PRODUCTS For: Dec 31
-
Form 24F-2NT TFLIC SEPARATE ACCOUNT For: Dec 31
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 4 ESSA Pharma Inc. For: Mar 25 Filed by: Martin John Alexander
-
Form X-17A-5 PRIME CAPITAL MARKETS, For: Dec 31
-
Form 497 COLI VUL-4 Series Accoun
-
Form 424B2 CITIGROUP INC
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 4 ESSA Pharma Inc. For: Mar 25 Filed by: Kantoff Philip W.
-
Form 424B2 UBS AG
-
Form 144 Kinetik Holdings Inc. Filed by: Carpenter Todd
-
Form 24F-2NT RETIREMENT BUILDER VARIA For: Dec 31
-
Form 424B2 UBS AG
-
Form 4 ESSA Pharma Inc. For: Mar 25 Filed by: Glickman Richard M
-
Form 424B2 UBS AG
-
Form 4 ESSA Pharma Inc. For: Mar 25 Filed by: BERGER FRANKLIN M
-
Form 24F-2NT TFLIC SEPARATE ACCOUNT For: Dec 31